Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.360
-0.060 (-1.75%)
At close: Sep 8, 2026, 4:00 PM EDT
3.366
-0.054 (-1.57%)
After-hours: Sep 8, 2026, 7:42 PM EDT
Altimmune Market Cap
Altimmune has a market cap or net worth of $653.58 million as of September 8, 2026. Its market cap has increased by 95.91% in one year.
Market Cap
653.58M
Enterprise Value
363.32M
1-Year Change
95.91%
Ranking
Category
Stock Price
$3.36
ChartMarket Cap Chart
Since May 5, 2017, Altimmune's market cap has decreased from $2.19B to $653.58M, a decrease of -70.18%. That is a compound annual growth rate of -12.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 653.58M | 65.86% |
| Dec 31, 2025 | 394.05M | -23.16% |
| Dec 31, 2024 | 512.81M | -15.16% |
| Dec 29, 2023 | 604.45M | -25.23% |
| Dec 30, 2022 | 808.45M | 122.62% |
| Dec 31, 2021 | 363.14M | -12.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shattuck Labs | 681.47M |
| Allogene Therapeutics | 680.62M |
| Sagimet Biosciences | 680.02M |
| BlossomHill Therapeutics | 674.47M |
| MiMedx Group | 666.13M |
| Prime Medicine | 658.25M |
| CorMedix | 657.07M |
| Bright Minds Biosciences | 656.57M |